Pragmatic trials: lab meets bedside

G Kirtschig^{1

2}, S Lo^{3

4}, J Batchelor⁵; Clinical Trials Editorial Team of the British Journal of Dermatology

Affiliations

¹ Department of Dermatology, University of Marburg, Germany.
² Medbase Frauenfeld, santémed Gesundheitszentren AG, Frauenfeld, Switzerland.
³ Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
⁴ Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
⁵ Centre of Evidence Based Dermatology, University of Nottingham, Lenton Lane, Nottingham, NG7 2NR, U.K.

Editorial

G Kirtschig et al. Br J Dermatol. 2019 Sep.

. 2019 Sep;181(3):431-433.

doi: 10.1111/bjd.17889.

G Kirtschig^{1

2}, S Lo^{3

4}, J Batchelor⁵; Clinical Trials Editorial Team of the British Journal of Dermatology

¹ Department of Dermatology, University of Marburg, Germany.
² Medbase Frauenfeld, santémed Gesundheitszentren AG, Frauenfeld, Switzerland.
³ Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
⁴ Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
⁵ Centre of Evidence Based Dermatology, University of Nottingham, Lenton Lane, Nottingham, NG7 2NR, U.K.

No abstract available

References

1. Altman DG, Bland JM. Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ 1999; 318:1209.
1. Guyatt GH, Haynes RB, Jaeschke RZ et al. Users’ Guides to the medical literature: XXV. Evidence-based medicine: principles for applying the Users’ Guides to patient care. Evidence-Based Medicine Working Group. JAMA 2000; 284:1290-6.
1. Cochrane AL. Effectiveness and Efficiency. Random Reflections on Health Services. London, UK: Nuffield Provincial Hospitals Trust, 1972.
1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967; 20:637-48.
1. Sedgwick P. Explanatory trials versus pragmatic trials. BMJ 2014; 349:g6694.